These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1484 related articles for article (PubMed ID: 8612308)

  • 41. O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry.
    Christmann M; Verbeek B; Roos WP; Kaina B
    Biochim Biophys Acta; 2011 Dec; 1816(2):179-90. PubMed ID: 21745538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematopoietic expression of O(6)-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O(6)-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea.
    Kreklau EL; Pollok KE; Bailey BJ; Liu N; Hartwell JR; Williams DA; Erickson LC
    Mol Cancer Ther; 2003 Dec; 2(12):1321-9. PubMed ID: 14707273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-29c contribute to glioma cells temozolomide sensitivity by targeting O6-methylguanine-DNA methyltransferases indirectely.
    Xiao S; Yang Z; Qiu X; Lv R; Liu J; Wu M; Liao Y; Liu Q
    Oncotarget; 2016 Aug; 7(31):50229-50238. PubMed ID: 27384876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The specific role of O
    Sun G; Zhao L; Zhong R; Peng Y
    Future Med Chem; 2018 Aug; 10(16):1971-1996. PubMed ID: 30001630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo.
    Chen TC; Cho HY; Wang W; Nguyen J; Jhaveri N; Rosenstein-Sisson R; Hofman FM; Schönthal AH
    Cancer Lett; 2015 Mar; 358(2):144-151. PubMed ID: 25524552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT.
    Christmann M; Pick M; Lage H; Schadendorf D; Kaina B
    Int J Cancer; 2001 Apr; 92(1):123-9. PubMed ID: 11279615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo.
    Marathi UK; Dolan ME; Erickson LC
    Biochem Pharmacol; 1994 Nov; 48(11):2127-34. PubMed ID: 7802703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study.
    Middleton MR; Lee SM; Arance A; Wood M; Thatcher N; Margison GP
    Int J Cancer; 2000 Nov; 88(3):469-73. PubMed ID: 11054678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. O6-methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor induced resistance against temozolomide in human melanoma cells.
    Fontijn D; Adema AD; Bhakat KK; Pinedo HM; Peters GJ; Boven E
    Mol Cancer Ther; 2007 Oct; 6(10):2807-15. PubMed ID: 17938272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter.
    Alonso MM; Gomez-Manzano C; Bekele BN; Yung WK; Fueyo J
    Cancer Res; 2007 Dec; 67(24):11499-504. PubMed ID: 18089777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
    Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
    Liu L; Schwartz S; Davis BM; Gerson SL
    Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines.
    Mineura K; Fukuchi M; Kowada M; Terashima I; Kohda K
    Int J Cancer; 1995 Sep; 63(1):148-51. PubMed ID: 7558444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice.
    Hansen RJ; Nagasubramanian R; Delaney SM; Samson LD; Dolan ME
    Carcinogenesis; 2007 May; 28(5):1111-6. PubMed ID: 17116724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic and molecular profiling predicts response to temozolomide in melanoma.
    Augustine CK; Yoo JS; Potti A; Yoshimoto Y; Zipfel PA; Friedman HS; Nevins JR; Ali-Osman F; Tyler DS
    Clin Cancer Res; 2009 Jan; 15(2):502-10. PubMed ID: 19147755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFκB and mutant p53.
    Vlachostergios PJ; Hatzidaki E; Papandreou CN
    Neurol Res; 2013 Oct; 35(8):879-82. PubMed ID: 23561593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines.
    Murakami J; Lee YJ; Kokeguchi S; Tsujigiwa H; Asaumi J; Nagatsuka H; Fukui K; Kuroda M; Tanaka N; Matsubara N
    Oncol Rep; 2007 Jun; 17(6):1461-7. PubMed ID: 17487405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of nitrosourea-resistant human rhabdomyosarcomas by in situ immunostaining of O6-methylguanine-DNA methyltransferase.
    Brent TP; von Wronski MA; Edwards CC; Bromley M; Margison GP; Rafferty JA; Pegram CN; Bigner DD
    Oncol Res; 1993; 5(2):83-6. PubMed ID: 8364257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts.
    Middleton MR; Kelly J; Thatcher N; Donnelly DJ; McElhinney RS; McMurry TB; McCormick JE; Margison GP
    Int J Cancer; 2000 Jan; 85(2):248-52. PubMed ID: 10629085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.